Thursday, April 21, 2016

UPDATE 3-Cost cutting helps Biogen top Wall Street estimates for quarter

* 1st-qtr profit $4.79/shr vs est. $4.47

(Adds company, analyst comment, share move)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)